← Back to Clinical Trials
Recruiting NCT07582016

NCT07582016 Partnership to Reduce Obesity in Community Health Center Patients (SMARTLife Utah)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07582016
Status Recruiting
Phase —
Sponsor University of Utah
Condition Obesity
Study Type INTERVENTIONAL
Enrollment 5,354 participants
Start Date 2026-07-01
Primary Completion 2029-04

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Ask-Advise-Connect (AAC)Text Messaging (TM)Connect Only (CO)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 5,354 participants in total. It began in 2026-07-01 with a primary completion date of 2029-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The long-term objective of SMARTLife Utah is to increase the reach of existing digital EBIs for obesity among patients of Community Health Centers (CHCs). SMARTLife Utah will be conducted in up to 11 Community Health Center (CHC) systems, consisting of 38 primary care clinics. SMARTLife Utah is a hybrid Type III effectiveness-implementation design, utilizing a pragmatic, multilevel, three-phase Sequential Multiple Assignment Randomized Trial (SMART). SMARTLife Utah leverages ubiquitous health information technology(HIT)/telehealth for both the implementation strategies and Evidence-Based Intervention (EBI) delivery in order to address barriers for engaging in EBIs. Implementation strategies target two different levels to increase the reach of EBIs: 1. a clinic-level HIT implementation strategy that includes enhanced system supports at the point of care; and 2. patient-level implementation strategies that provide repeated opportunities to enroll in EBIs, as well as motivation/practical problem-solving to facilitate enrollment.

Eligibility Criteria

Inclusion Criteria: * 18 years old or older * BMI ≥ 30 * Speak either English or Spanish * Present at the participating clinic * Valid cell phone number in the electronic health record (EHR) * EHR indicates they have not opted out of receiving text messages from the clinic Exclusion Criteria: * Currently pregnant

Contact & Investigator

Central Contact

Chelsey Schlechter, PhD

✉ chelsey.schlechter@hci.utah.edu

📞 801-213-5704

Principal Investigator

Chelsey Schlechter, PhD

PRINCIPAL INVESTIGATOR

Huntsman Cancer Institute

Frequently Asked Questions

Who can join the NCT07582016 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07582016 currently recruiting?

Yes, NCT07582016 is actively recruiting participants. Contact the research team at chelsey.schlechter@hci.utah.edu for enrollment information.

Where is the NCT07582016 trial being conducted?

This trial is being conducted at Salt Lake City, United States.

Who is sponsoring the NCT07582016 clinical trial?

NCT07582016 is sponsored by University of Utah. The principal investigator is Chelsey Schlechter, PhD at Huntsman Cancer Institute. The trial plans to enroll 5,354 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology